
Martin P Carroll MD
Associate Professor, Medicine, Perelman School of Medicine
Join to View Full Profile
3400 Spruce St"# 15"Philadelphia, PA 19104
Phone+1 215-662-3914
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Martin Carroll, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is an Associate Professor at Perelman School of Medicine.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1997
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1988 - 1991
- Geisel School of Medicine at DartmouthClass of 1988
Certifications & Licensure
- PA State Medical License 1998 - 2026
Publications & Presentations
PubMed
- Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.Margaret Rowe, Daria Babushok, Martin Carroll, Alison Carulli, Noelle Frey
European Journal of Haematology. 2025-04-01 - Persistent post-remission clonal hematopoiesis shapes the relapse trajectories of acute myeloid leukemia.Ryan D Chow, Priya Velu, Safoora Deihimi, Jonathan P Belman, Angela Youn
Blood Advances. 2025-02-12 - 1 citationsAcquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia.Fiona C Brown, Xin Wang, Richard Birkinshaw, Chong Chyn Chua, Thomas Morley
Blood Advances. 2025-01-14
Press Mentions
- Genomic Features of AML in Patients over Age 60 Can Predict Success of Bone Marrow Stem Cell Transplant, Research ShowsDecember 6th, 2019
- Heterogeneity of Human Bone Marrow and Blood Natural Killer Cells Defined by Single-Cell TranscriptomeSeptember 2nd, 2019
- Germline Duplication of ATG2B and GSKIP Genes Is Not Required for the Familial Myeloid Malignancy Syndrome Associated with the Duplication of Chromosome 14q32August 7th, 2018